Once you reach a maintenance dosage, you will have regular interval check-ins to discuss your treatment and the appropriateness of new prescriptions
Retatrutide is an investigational triple agonist peptide currently under clinical development, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
With the increased satiety from GLP-1 analogues, weight loss is quite promising
They can be dangerous or ineffective
Heres how we help patients achieve success with our GLP-1 weight loss program in Plantation, FL: 1 Focus on Nutrition and Protein GLP-1s reduce appetite naturally, but its still important to choose nutrient-dense foods
Both start at a dose intended to be well below the therapeutic threshold, primarily serving as an acclimation period for the GI system